% | $
Quotes you view appear here for quick access.

Chelsea Therapeutics Internation Message Board

  • neurodragon007 neurodragon007 Sep 5, 2013 9:31 AM Flag

    Here we go

    Analysts at Ladenburg Thalmann lifted their price target on shares of Chelsea Therapeutics International from $3.50 to $4.00 in a research report issued to clients and investors on Thursday 9/5. The firm currently has a BUY rating on the stock. Ladenburg Thalmann’s price objective would suggest a potential upside of 29.45% from the company’s current price.

    Sentiment: Strong Buy